Scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.
Studies with rats found the treatment can reverse changes in blood vessels in the brain associated with the condition, called cerebral small vessel disease.
Treatment also prevents damage to brain cells caused by these blood vessel changes, raising hope that it could offer a therapy for dementia.
Small vessel disease, or SVD, is a major cause of dementia and can also worsen the symptoms of Alzheimer’s disease. It is responsible for almost half of all dementia cases in the UK and is a major cause of stroke, accounting for around one in five cases.
Patients with SVD are diagnosed from brain scans, which detect damage to white matter – a key component of the brain’s wiring.
Until now, it was not known how changes in small blood vessels in the brain associated with SVD can cause damage to brain cells.
A team led by the University of Edinburgh found that SVD occurs when cells that line the small blood vessels in the brain become dysfunctional. This causes them to secrete a molecule into the brain.
The molecule stops production of the protective layer that surrounds brain cells – called myelin – which leads to brain damage.
Treating rats with drugs that stop blood vessel cells from becoming dysfunctional reversed the symptoms of SVD and prevented brain damage, tests found.
Researchers say that further studies will need to test whether the treatment also works when the disease is firmly established. They will also need to check if the treatment can reverse the symptoms of dementia.
Dementia is one of the biggest problems facing society, as people live longer and the population ages. Estimates indicate there are almost 47 million people living with dementia worldwide and the numbers affected are expected to double every 20 years, rising to more than 115 million by 2050.
The research, published in Science Translational Medicine, was carried out at the Medical Research Council Centre for Regenerative Medicine and the UK Dementia Research Institute at the University of Edinburgh. It was funded by the MRC, Alzheimer’s Research UK and Fondation Leducq.
Professor Anna Williams, Group Leader at the University of Edinburgh’s MRC Centre for Regenerative Medicine, said: “This important research helps us understand why small vessel disease happens, providing a direct link between small blood vessels and changes in the brain that are linked to dementia. It also shows that these changes may be reversible, which paves the way for potential treatments.”
Dr Sara Imarisio, Head of Research at Alzheimer’s Research UK said: “Changes to the blood supply in the brain play an important role in Alzheimer’s disease as well as being a direct cause of vascular dementia. This pioneering research highlights a molecular link between changes to small blood vessels in the brain and damage to the insulating ‘white matter’ that helps nerve cells to send signals around the brain.
“The findings highlight a promising direction for research into treatments that could limit the damaging effects of blood vessel changes and help keep nerve cells functioning for longer. There are currently no drugs that slow down or stop Alzheimer’s disease and no treatments to help people living with vascular dementia. Alzheimer’s Research UK is very pleased to have helped fund this innovative research, which is only possible thanks to the work of our dedicated supporters.”
The Latest on: Small vessel disease
via Google News
The Latest on: Small vessel disease
- Eight Aussie babies born each day with congenital heart diseaseon September 6, 2019 at 10:29 am
Eva was found to have Truncus Arteriosus, a rare condition where there is only one blood vessel coming out of the heart instead ... for the eight Australian babies born every day with heart disease.
- Quick Take: Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosison September 6, 2019 at 3:04 am
At baseline, 38.9% of patients had RRMS, 23.4% had cerebral small vessel disease, 19.3% of patients had clinically isolated syndrome, 5.3% had aquaporin-4 antibody-positive NMOSD, 4.8% had migraine, 4 ...
- 'I know I will have another stroke. It's just when' - Norfolk man on facing up to incurable brain diseaseon September 3, 2019 at 8:40 am
So it was really nice to celebrate with close friends and family." Both he and Karen are participants a University of Cambridge study looking at people with small vessel disease. He is also a Cadasil ...
- Treatable Blood Vessel Leakage Could be Answer to Severe Dengue Diseaseon August 30, 2019 at 7:29 am
While most patients experience dengue fever or a mild form of the disease, a small percentage develops dengue hemorrhagic ... By studying human blood vessel cells cultured on microscope slides, “we ...
- Avinger Announces 50th Patient Treated in Pantheris SV Initial Launchon August 29, 2019 at 5:07 am
catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported significant progress in the initial U.S. launch of the Pantheris SV (small vessel) image-guided ...
- Promising new strategy to treat severe dengue disease on the horizonon August 27, 2019 at 7:52 pm
While most patients experience dengue fever or a mild form of the disease, a small percentage develops dengue hemorrhagic ... tryptase cuts the proteins that act as seals between blood vessel cells, ...
- Possible treatment on the horizon for severe dengue diseaseon August 27, 2019 at 8:09 am
While most patients experience dengue fever or a mild form of the disease, a small percentage develops dengue haemorrhagic ... tryptase cuts the proteins that act as seals between blood vessel cells, ...
- PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activityon August 27, 2019 at 2:19 am
Diagnosis of large vessel vasculitis (LVV) and evaluation of its inflammatory ... 2 [1.8–2.6] in patients with active disease vs. remission, respectively (p = 0.003). PET/MRI is a new hybrid imaging ...
- SPRINT MIND: Intensive BP treatment beneficial in cerebral small vessel ischemic diseaseon August 13, 2019 at 8:46 am
Patients with hypertension whose target systolic BP was less than 120 mm Hg had a greater decrease in total brain volume and a smaller increase in cerebral white matter lesion volume compared with ...
via Bing News